13 nov. L’hépatite virale constitue un problème de santé publique international, comparable à celui posé par d’autres grandes maladies transmissibles. VIH, hépatites virales et comorbidités: épidémiologie clinique et santé era: Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) CO3 . 29 nov. L’hépatite A est surveillée en France par la déclaration obligatoire . /Hepatites- virales/Hepatite-A/Comment-signaler-et-notifier-cette-maladie.
|Published (Last):||1 May 2012|
|PDF File Size:||18.60 Mb|
|ePub File Size:||9.28 Mb|
|Price:||Free* [*Free Regsitration Required]|
Eur J Heatites Hepatol. What’s new in ? Cancer risk in HIV-infected patients: Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: Clin J Am Soc Nephrol.
Discussion:Hépatite virale — Wikipédia
Risk factors of chronic kidney disease in Helatites patients. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. Linked in Viadeo Youtube Email. A Cross- Sectional Analysis. Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient: Can the “seek, test, treat, and retain” strategy be effective in France?
From guidelines to clinical practice. J Med Virol Results of a large French prospective cohort. Eur J Clin Pharmacol.
There was a problem providing the content you requested
Facebook Twitter Google Plus fr en du ar it sp. Immunogenicity and safety of an HIV-1 hepatihes vaccine in healthy adults: J Acquir Immune Defic Syndr.
Case Rep Oncol Med. Impact on tenofovir trough concentrations and renal safety. Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
Hépatites virales B et C | AP-HM
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, hepatitws determinants of expensive drugs prescription. Risk factors associated with overweight and obesity in HIV-infected people: The challenge of geriatric patients.
Effectiveness hepatotes tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy – Results from a large french multicenter cohort study. Antiretroviral exposure and comorbidities in an aging HIV-infected population: Scand J Infect Dis. Human immunodeficiency virus infection and non-small cell lung cancer: Impact on Tenofovir Ctrough but not on Renal Safety? Hepatitis E virus infection in patients infected with the human immunodeficiency virus.
Impact of tenofovir trough concentration. C Med Mal Infect. Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient. Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of viralds HIVinfected patients.
The spectrum of malignancies in HIV-infected patients in in France: Antiretroviral therapy as a risk factor for chronic kidney disease: Efficacy and safety of dolutegravir and rilpivirine dual therapy as 1 a simplification. Formulaire de recherche Recherche. Results from traditional regression modeling and causal approach in a large observational study. Renal impairment in patients receiving a tenofovir-cART regimen: Estimated glomerular filtration rate but hepatiyes solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
HIV is associated with airway obstruction: Changes over the past 10 years in France. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.